Véronia Safwat

Since 2015, Veronia was involved in numerous clinical trials from phase I to phase IV, mainly in oncology (solid tumors and lymphoma as well) as CRA and then as Lead CRA. She works for numerous CROs such as Altizem, Aepodia, DOCS/ICON or Labcorp.